|
Feb 21
|
Ardelyx Inc (ARDX) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Challenges
|
|
Feb 21
|
Q4 2024 Ardelyx Inc Earnings Call
|
|
Feb 20
|
Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say
|
|
Feb 20
|
Ardelyx (ARDX) Meets Q4 Earnings Estimates
|
|
Feb 20
|
Ardelyx: Q4 Earnings Snapshot
|
|
Feb 20
|
Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
|
|
Feb 19
|
Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference
|
|
Feb 17
|
BioCryst Pharmaceuticals (BCRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Feb 13
|
Ardelyx (ARDX) Earnings Expected to Grow: Should You Buy?
|
|
Dec 30
|
Why Ardelyx (ARDX) Is One of the Best Biotech Penny Stocks to Invest in Now?
|
|
Dec 30
|
Exploring 3 High Growth Tech Stocks in the United States
|
|
Oct 9
|
Ardelyx Inc (ARDX) Q2 2024 Earnings Call Highlights: Revenue Surge and Strategic Challenges
|
|
Oct 9
|
Even though Ardelyx (NASDAQ:ARDX) has lost US$210m market cap in last 7 days, shareholders are still up 352% over 3 years
|
|
Oct 9
|
Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology
|
|
Oct 7
|
Wall Street Analysts Think Ardelyx (ARDX) Could Surge 65.4%: Read This Before Placing a Bet
|
|
Sep 5
|
Ardelyx to Participate at the 2024 Cantor Global Healthcare Conference
|
|
Aug 30
|
With 62% ownership, Ardelyx, Inc. (NASDAQ:ARDX) boasts of strong institutional backing
|
|
Jul 29
|
Will BioCryst Pharmaceuticals (BCRX) Report Negative Earnings Next Week? What You Should Know
|
|
Jul 25
|
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jun 22
|
When Will Ardelyx, Inc. (NASDAQ:ARDX) Become Profitable?
|